The Street's Adam Feuerstein makes 13 biotech stock predictions for 2013, with his number one being that the U.S. launch of Arena Pharmaceuticals' (ARNA) and Eisai's weight-loss pill Belviq "will be a major disappointment." Feuerstein also reckons that Belviq will fail to receive European approval.
The Street's Adam Feuerstein makes 13 biotech stock predictions for 2013, with his number one...
From other sites
at CNBC.com (Jan 7, 2015)
at CNBC.com (Nov 3, 2014)
Video at CNBC.com (Nov 3, 2014)
at CNBC.com (Oct 27, 2014)
at CNBC.com (Sep 11, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs